Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Ex-Vaccine Panelist Speaks Out on Firing, New Committee

Thursday, June 26, 2025 The federal Advisory Committee on Immunization Practices (ACIP) has been soberly and deliberately helping set U.S. vaccination policy fo

Typos, Slang Trip Up AI Medical Assessments

THURSDAY, June 26, 2025 Common human typing errors can trip up artificial intelligence (AI) programs designed to aid health care workers by reviewing health rec

Online Videos For Kids Rife With Junk Food Messaging

THURSDAY, June 26, 2025 Kids watching YouTube videos are being hammered with messages promoting junk food like candy, sugary drinks, fast food and sweet or salt

NIH Stops Canceling Research Grants Following Court Ruling

THURSDAY, June 26, 2025 The National Institutes of Health (NIH) has stopped canceling biomedical research grants after a federal judge said hundreds of those cu

Illinois Reports First West Nile Virus Case of 2025

THURSDAY, June 26, 2025 Illinois has confirmed its first human case of West Nile virus this year, health officials say. The person, who lives in southern Illino

CDC Pulls Vaccine Slide After Expert Cites Study Doesn’t Exist

THURSDAY, June 26, 2025 A presentation scheduled for a U.S. Centers for Disease Control and Prevention (CDC) vaccine meeting today claimed that a vaccine preser

Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Netherton Syndrome

Quoin Pharmaceuticals Ltd. (NASDAQ QNRX) ( Quoin or the Company ), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, t

Nuvalent Announces Positive Pivotal Data from ARROS-1 Clinical Trial of Zidesamtinib for TKI Pre-treated Patients with Advanced ROS1-Positive NSCLC

Nuvalent, Inc. (Nasdaq NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets i

Riliprubart Earns Orphan Drug Designation in the US for Antibody-Mediated Rejection in Solid Organ Transplantation

Paris, June 25, 2025. The US Food and Drug Administration (FDA) has granted orphan drug designation to riliprubart for the investigational treatment of antibody

Popular Keywords